Clinical Trial Update: Effect of Ketoconazole on the Pharmacokinetics of Vinflunine [Phase 1]

View source ↗

Summary

A Phase 1 study update evaluating how ketoconazole changes the pharmacokinetics of vinflunine in cancer patients, sponsored by Bristol-Myers Squibb.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Ketoconazole (Ketoconazole)
• Vinflunine (vinflunine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cancer | Phase 1 | Status: COMPLETED